Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs Mirabegron

    Virtual Booth

    Contact Supplier

    Mirabegron

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem Mirabegron

    Virtual Booth

    Contact Supplier

    Mirabegron

    Virtual Booth

    Contact Supplier

    Menu

    Mirabegron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Pharmathen SA

    02 3APGDI

    03 1Adalvo

    04 3Alkem Laboratories

    05 2Alter Laboratories Sa

    06 2Apotex Inc

    07 20Astellas Pharma

    08 1Aurobindo Pharma Limited

    09 1Avansor Pharma Oy

    10 1CLONMEL HLTHCARE

    11 1Cinfa

    12 2Cipla Medpro South Africa

    13 1GSK

    14 1Glenmark Pharmaceuticals

    15 2KMS Health Center

    16 1LABORATORIOS NORMON SA

    17 2Lupin Ltd

    18 2MSN Laboratories

    19 1Q Pharma Laboratories Sl

    20 2Qilu Pharmaceutical

    21 3STADA Arzneimittel

    22 2Sawai Pharmaceutical Co

    23 1Sunshine Lake Pharma

    24 2Tecnimede

    25 3Teva Pharmaceutical Industries

    26 2Unichem Laboratories Limited

    27 1Whanin Pharmaceutical

    28 4Zentiva

    29 2Zydus Pharmaceuticals

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Pharmathen SA

    Greece
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

    Contact Supplier Contact Supplier
    Flag Greece
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Greece

    Mirabegron

    Brand Name :

    Dosage Form : Prolonged Release Tablet

    Dosage Strength : 25MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Greece

    Pharmathen

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Pharmathen SA

    Greece
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

    Contact Supplier Contact Supplier
    Flag Greece
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Greece

    Mirabegron

    Brand Name :

    Dosage Form : Prolonged Release Tablet

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Greece

    Pharmathen

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Alkem Laboratories

    India
    BPI Europe
    Not Confirmed
    arrow

    Alkem Laboratories

    India
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2024-02-12

    Application Number : 215948

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Alkem Laboratories

    India
    BPI Europe
    Not Confirmed
    arrow

    Alkem Laboratories

    India
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2024-02-12

    Application Number : 215948

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    APGDI

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    APGDI

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MYRBETRIQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2012-06-28

    Application Number : 202611

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    APGDI

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    APGDI

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MYRBETRIQ

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2012-06-28

    Application Number : 202611

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    APGDI

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    APGDI

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MYRBETRIQ GRANULES

    Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL

    Dosage Strength : 8MG/ML

    Packaging :

    Approval Date : 2021-03-25

    Application Number : 213801

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Apotex Inc

    Canada
    BPI Europe
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2025-01-02

    Application Number : 209434

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Apotex Inc

    Canada
    BPI Europe
    Not Confirmed
    arrow

    Apotex Inc

    Canada
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2025-01-02

    Application Number : 209434

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Aurobindo Pharma Limited

    India
    BPI Europe
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number : 209413

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    Lupin Ltd

    India
    arrow
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2022-09-28

    Application Number : 209485

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    Lupin Ltd

    India
    arrow
    CPhI Milan
    Exhibiting
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2022-09-28

    Application Number : 209485

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    MSN Laboratories

    India
    BPI Europe
    Not Confirmed
    arrow

    MSN Laboratories

    India
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2025-11-04

    Application Number : 218543

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    Qilu Pharmaceutical

    China
    BPI Europe
    Not Confirmed
    arrow

    Qilu Pharmaceutical

    China
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2025-06-30

    Application Number : 217989

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    Qilu Pharmaceutical

    China
    BPI Europe
    Not Confirmed
    arrow

    Qilu Pharmaceutical

    China
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2025-06-30

    Application Number : 217989

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    Sawai Pharmaceutical Co

    Japan
    BPI Europe
    Not Confirmed
    arrow

    Sawai Pharmaceutical Co

    Japan
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2019-12-27

    Application Number : 209446

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Sawai Pharmaceutical Co

    Japan
    BPI Europe
    Not Confirmed
    arrow

    Sawai Pharmaceutical Co

    Japan
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2025-05-06

    Application Number : 217061

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Sunshine Lake Pharma

    China
    BPI Europe
    Not Confirmed
    arrow

    Sunshine Lake Pharma

    China
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE

    Dosage Strength : 25MG

    Packaging :

    Approval Date :

    Application Number : 216757

    Regulatory Info :

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Zydus Pharmaceuticals

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 25MG

    Packaging :

    Approval Date : 2022-09-29

    Application Number : 209488

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Zydus Pharmaceuticals

    U.S.A
    BPI Europe
    Not Confirmed
    arrow

    Zydus Pharmaceuticals

    U.S.A
    arrow
    BPI Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    MIRABEGRON

    Brand Name : MIRABEGRON

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 50MG

    Packaging :

    Approval Date : 2022-09-29

    Application Number : 209488

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.